Abstract
To examine the effect of comorbidity on risk of postoperative complications, prolonged hospitalization (defined as above median length of stay), non-routine disposition, and in-patient death among women with breast cancer after surgery. Nationwide in-patient sample is a nationwide clinical and administrative database. Discharges of patients aged 40 years and older who underwent surgery for breast cancer from 2005 to 2009 were identified. Information about patients and hospitals characteristics were obtained. Comorbidities were identified and used to calculate Charlson comorbidity index (CCI) score. We divided patients based on these scores into four groups: 0, 1, 2, and ≥3. Multivariate logistic regression analyses were used to examine risk adjusted association between CCI score and the aforementioned outcomes. We identified 70,536 patients’ discharges. Compared to a CCI score of zero as a reference group, CCI scores of 1, 2, and ≥3 increased the risk of post-operative complications by 1.7-fold, 2.6-fold, and 4.6-fold, respectively (p < 0.001). Patients with CCI scores of 1, 2, and ≥3 had higher risk of non-routine disposition by 1.3-folds, 1.7-folds, and 2.2-folds, respectively (p < 0.001). Patients with CCI scores of 1, 2, and ≥3 had higher risk of prolonged hospitalization by 1.2-folds, 1.6-folds, and 2.3-folds, respectively (p < 0.001). Similarly, CCI scores of 1, 2, and ≥3 increased risk of in-patient death by 3.1-folds (p 0.05), 5.4-folds (p 0.008), and 15.8-folds (p < 0.001), respectively. Comorbidity associated with worse in-hospital outcomes among women with breast cancer after surgery. Effective control of comorbidity in breast cancer patients may reduce post-operative morbidity and mortality.
Similar content being viewed by others
References
Gijsen R, Hoeymans N, Schellevis FG et al (2001) Causes and consequences of comorbidity: a review. J Clin Epidemiol 54:661–674
Bergman L, Dekker G, Van Kerkhoff EH et al (1991) Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat 18:189–198
Yancik R, Wesley MN, Ries LA et al (2011) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885–892
Greenfield S, Blanco DM, Elashoff RM et al (1987) Patterns of care related to age of breast cancer patients. JAMA 257:2766–2770
Cleary PD, Greenfield S, Mulley AG et al (1991) Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 266:73–79
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619
Greenfield S, Apolone G, McNeil BJ et al (1993) The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 31:141–154
Kaplan MH, Feinstein AR (1974) The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27:387–404
Jencks SF, Williams DK, Kay TL (1988) Assessing hospital associated deaths from discharge data: the role of length of stay and comorbidities. JAMA 260:2240–2246
HCUP Databases (2011) Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 23 Jan 2013
Publications from the HCUP Databases (2011) Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (HCUP). http://www.hcup-us.ahrq.gov/reports/pubsearch/pubsearch.jsp. Accessed 23 Jan 2013
Zhang S, Ivy JS, Payton FC et al (2010) Modeling the impact of comorbidity on breast cancer patient outcomes. Health Care Manag Sci 13:137–154
Polek C, Klemm P, Hardie T et al (2004) Asian/Pacific Islander American women: age and death rates during hospitalization for breast cancer. Oncol Nurs Forum 31:69–74
Kotwall C, Brinker C, Covington D et al (2003) Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ. Am J Surg 186:723–728
Case C, Johantgen M, Steiner C (2001) Outpatient mastectomy: clinical, payer, and geographic influences. Health Serv Res 36:869–884
Reuben BC, Manwaring J, Neumayer LA (2009) Recent trends and predictors in immediate breast reconstruction after mastectomy in the United States. Am J Surg 198:237–243
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139
Shavers VL, Harlan LC, Stevens JL (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97:1143–1147
Dimick JB, Wainess RM, Upchurch GR et al (2005) National trends in outcomes for esophageal resection. Ann Thorac Surg 79:212–216
Finlayson EV, Goodney PP, Birkmeyer JD (2003) Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg 138:721–725
Guller U, Safford S, Pietrobon R et al (2005) High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 Patients. World J Surg 29:994–1000
Birkmeyer JD, Siewers AE, Finlayson EVA et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137
Gonnella JS (1996) Disease Staging, 4th edn. The MEDSTAT Group, SysteMetrics Division, Ann Arbor
Iezzoni LI, Ash AS, Shwartz M et al (1995) Predicting who dies depends on how severity is measured: implications for evaluating patient outcomes. Ann Intern Med 123:763–770
Houterman S, Janssen-Heijnen ML, Verheij CD et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90:2332–2337
Librero J, Peiro S, Ordnana R (1999) Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol 52:171–179
Land LH, Dalton SO, Jensen MB et al (2012) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008. Breast Cancer Res Treat 131:1013–1020
Ahem TP, Lash TL, Thwin SS et al (2009) Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Med Care 47:73–79
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dehal, A., Abbas, A. & Johna, S. Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database. Breast Cancer Res Treat 139, 469–476 (2013). https://doi.org/10.1007/s10549-013-2543-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-013-2543-9